Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 19, 2017 Filed Apr 21, 2017 21:50 UTC |
Maynard Ryan DEVP & CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001179110-17-006153 · edgar.xml · derivative · entry 2 Maynard Ryan D · CIK 0001363984 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2026-01-26 F2 · derivative.exercise_date: On January 26, 2016 the reporting person was granted an option to purchase 150,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On April 19, 2017, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:50 UTC |
Maynard Ryan DEVP & CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 62,500 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001179110-17-006153 · edgar.xml · derivative · entry 1 Maynard Ryan D · CIK 0001363984 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2024-02-27 F1 · derivative.exercise_date: On February 27, 2014 the reporting person was granted an option to purchase 125,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. As previously reported on April 4, 2016, the Compensation Committee determined that the performance condition had been achieved with respect to 62,500 shares of common stock. On April 19, 2017, the Compensation Committee determined that the performance conditions had been achieved with respect to the remaining 62,500 shares of common stock, resulting in full vesting of the option. Read SEC document |
| February 02, 2017 Filed Feb 7, 2017 00:33 UTC |
Lasaga JosephVP Bus. Dev.& Alliance Mgmt.
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-17-001828 · edgar.xml · derivative · entry 1 Lasaga Joseph · CIK 0001686916 · VP Bus. Dev.& Alliance Mgmt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-02-02 F1 · derivative.exercise_date: The shares vest monthly over four (4) years from January 1, 2017. Read SEC document |
| February 02, 2017 Filed Feb 7, 2017 00:30 UTC |
Masuda EstebanSr. VP Research
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-17-001827 · edgar.xml · derivative · entry 1 Masuda Esteban · CIK 0001686849 · Sr. VP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-02-02 F1 · derivative.exercise_date: The shares vest monthly over four (4) years from January 1, 2017. Read SEC document |
| February 02, 2017 Filed Feb 7, 2017 00:25 UTC |
Duliege Anne-MarieChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-17-001818 · edgar.xml · derivative · entry 1 Duliege Anne-Marie · CIK 0001419579 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2027-02-02 F1 · derivative.exercise_date: The shares vest monthly over four (4) years from January 1, 2017. Read SEC document |
| February 02, 2017 Filed Feb 7, 2017 00:27 UTC |
Mayer Eldon C. IIIEVP & Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-17-001821 · edgar.xml · derivative · entry 1 Mayer Eldon C. III · CIK 0001686952 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-02-02 F1 · derivative.exercise_date: The shares vest monthly over four (4) years from January 1, 2017. Read SEC document |
| February 02, 2017 Filed Feb 7, 2017 00:24 UTC |
Maynard Ryan DEVP & CFO
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-17-001817 · edgar.xml · derivative · entry 1 Maynard Ryan D · CIK 0001363984 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2027-02-02 F1 · derivative.exercise_date: The shares vest monthly over four (4) years from January 1, 2017. Read SEC document |
| February 02, 2017 Filed Feb 7, 2017 00:23 UTC |
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-17-001816 · edgar.xml · derivative · entry 1 VANCE DOLLY · CIK 0001237676 · EVP Corp. Affairs, G.C., Sect. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2027-02-02 F1 · derivative.exercise_date: The shares vest monthly over four (4) years from January 1, 2017. Read SEC document |
| February 02, 2017 Filed Feb 7, 2017 00:22 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantStock Option (Right to Buy) · Derivative | 450,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-17-001814 · edgar.xml · derivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2027-02-02 F1 · derivative.exercise_date: The shares vest monthly over four (4) years from January 1, 2017. Read SEC document |
| January 03, 2017 Filed Jan 13, 2017 23:02 UTC |
Duliege Anne-MarieChief Medical Officer
|
SaleCommon Stock | 5,000 | $2.41 | $12,027.50 |
DisclosureSEC source: 0001179110-17-000942 · edgar.xml · nonDerivative · entry 2 Duliege Anne-Marie · CIK 0001419579 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2016 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.36 to $2.44, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote three (3) of this Form 4. Read SEC document |
| October 10, 2016 Filed Oct 12, 2016 00:51 UTC |
Lasaga JosephVP Bus. Dev.& Alliance Mgmt.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $3.92 | $0.00 |
DisclosureSEC source: 0001179110-16-030657 · edgar.xml · derivative · entry 1 Lasaga Joseph · CIK 0001686916 · VP Bus. Dev.& Alliance Mgmt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2026-10-10 F1 · derivative.exercise_date: Common Stock subject to the Option shall vest over a four-year term, with one-fourth of the shares subject to the Option vesting on October 10, 2017, and 1/48th of the shares subject to the Option vesting monthly thereafter, subject to the Continuous Service (as defined in the Plan) to the Company through each vesting date. Read SEC document |
| October 10, 2016 Filed Oct 12, 2016 00:44 UTC |
Mayer Eldon C. IIIEVP &Chief Commercial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $3.92 | $0.00 |
DisclosureSEC source: 0001179110-16-030655 · edgar.xml · derivative · entry 1 Mayer Eldon C. III · CIK 0001686952 · EVP &Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2026-10-10 F1 · derivative.exercise_date: Common Stock subject to the Option shall vest over a four-year term, with one-fourth of the shares subject to the Option vesting on October 10, 2017, and 1/48th of the shares subject to the Option vesting monthly thereafter, subject to the Continuous Service (as defined in the Plan) to the Company through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.